News

A lawsuit claims a major breast implant maker knew its implants were likely causing cancer, and hid the complaints using fake company names

breast implant associated cancer fda
In a new letter to healthcare providers, the FDA said it wants to raise awareness of a rare cancer that's associated with breast implants. hxdbzxy/Shutterstock
Read in app

On August 16, two women filed a class-action lawsuit against major breast implant manufacturer Allergan after the company recalled its Biocell textured implants. The implants had been linked to a rare form of cancer called breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.

The women involved in the lawsuit are seeking monetary damages for themselves and other women with the implants because they "will be forced to expend substantial sums for the removal of the recalled implants, surgical and diagnostic fees, and/or medical monitoring and invasive diagnostic procedures required as a result of their exposure to the risk of contracting BIA-ALCL," according to lawsuit documents obtained by Insider.

As of September 2018, the FDA had received 457 unique reports of BIA-ALCL, including nine deaths "which may be attributable" to the cancer, according to a letter the FDA wrote to healthcare providers.

According to the lawsuit, Allergan also used fake names like "Costa Rica" and "Santa Barbra" instead of "Allergan" to hide the exact number of negative effects reports that people filed. The lawyers working on the lawsuit said these false reports violate the law and also put anyone with the Biocell textured implants at risk of misinformation.

Read more: Hundreds of Americans have developed a rare cancer that's linked to breast implants, and the FDA is urging doctors to stay alert

"As a result, consumers, healthcare professionals, and the FDA were unable to detect trends in Allergan's products, depriving the market of the necessary information to make an informed decision about whether Allergan's products were safe and effective," the lawsuit said.

Allergan has not responded to Insider's request for comment.

If you've developed BIA-ALCL or have Allergan's Biocell textured implants and would like to discuss your story, contact Julia Naftulin at jnaftulin@bjinnox.com.

Read the original article on INSIDER.

Follow INSIDER on Facebook.

Follow INSIDER on Twitter.

Read next

Headshot of Julia Naftulin
Julia Naftulin
Julia Naftulin is an editor on Business Insider's Special Projects team, where she leads editorial initiatives spanning the business, tech, and lifestyle spaces.She has launched and managed series covering how companies adopt and implement AIthe business of food, the 2026 World Cup, and innovation in supply chain management, as well as projects like the AI Power List.Previously, Julia served a five-year tenure as health reporter at Business Insider, covering general wellness and the intersection of relationships, psychology, and culture.Julia reported on the life of a Wall Street accountant-turned-professional-girlfriend, took readers inside Goop's first cruise, explored the dating industry, and delved into the latest plastic surgery trends. She was also Business Insider's resident relationship advice columnist, penning the now-defunct column Doing It Right.She has held editor roles at Health.com and Dotdash Meredith. Her work has been published in Health magazine and on Time, Apartment Therapy, The Knot, and Bicycling.com.Julia graduated from Syracuse University with a Bachelor of Science in Magazine Journalism. Julia lives in Philadelphia with her dachshund, Gretchen.